Home » Topics » BioWorld

BioWorld
RSS

ICOS CONFIRMS TALKS WITH GLAXO

Aug. 9, 1991

ANALYST IMPRESSED WITH GI's M-CSF

Aug. 9, 1991

SEPRACOR FILES 3.25 MILLION-SHARE IPO

Aug. 9, 1991

TWO IPOs CLOSE AT TOP PRICES

Aug. 8, 1991

CISTRON REGAINS IL-1 BETA RIGHTS

Aug. 8, 1991

ANERGEN FILES FOR 1.75-MILLION-SHARE IPO

Aug. 8, 1991

LIDAK GETS PATENT, SBIR FOR ANTI-VIRAL

Aug. 8, 1991

ANALYST BASHES XOMA AND CENTOCOR

Aug. 8, 1991

GLAXO CANADA INVESTS IN IAF BIOCHEM

Aug. 7, 1991

ARGUS GETS SBIR FOR IMMUNE SYSTEM MESSENGER

Aug. 7, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...